Trial ID or NCT#

NCT02582697

Status

RECRUITING

Purpose

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.

Official Title

Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

Eligibility Criteria

Ages Eligible for Study: 11 Years to 45 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Sheri Spunt
Pediatric oncologist, Sarcoma specialist
Endowed Professor of Pediatric Cancer

Contact us to find out if this trial is right for you.

CONTACT

Ruhi Nath
(650) 723-6990